Zambia has reached a five-year health financing agreement with the United States, with both countries expected to commit a combined $3.6 billion to healthcare services, following months of negotiations complicated by concerns over medical data privacy and access to critical mineral resources. The Zambian government confirmed that the agreement does not include provisions granting Washington access to the country’s abundant mineral resources, stressing that any negotiations involving critical minerals would be conducted separately.
Earlier discussions between Lusaka and Washington had reportedly stalled over concerns about the sharing of sensitive health information and proposals to link American financial assistance to access to Zambia’s strategically important mineral deposits. Zambia’s Health Minister, Roma Chilengi, said the government had secured assurances that information shared with the United States would be restricted to data necessary for monitoring and evaluating American-funded health programmes.
The agreement is expected to support healthcare delivery, disease prevention, medical services and other public health initiatives over five years.
However, the reported $3.6 billion represents the combined financial commitments of both governments, rather than funding provided exclusively by Washington. The development follows tensions between the two countries over the management of previously donated medical supplies.
In 2025, the United States announced the withdrawal of approximately $50 million in annual assistance to Zambia’s health sector, citing what American officials described as systemic theft of donated medicines and medical equipment.
The allegations raised concerns about accountability, distribution systems and oversight of internationally funded healthcare programmes.
The latest agreement forms part of a broader shift in Washington’s development assistance strategy under President Donald Trump, whose administration dismantled the United States Agency for International Development (USAID) and began pursuing direct bilateral health financing arrangements with African governments.
Under the new approach, participating countries are expected to progressively increase domestic healthcare spending while American financial contributions are gradually reduced. Washington argues that the arrangements are intended to strengthen national responsibility for healthcare financing and reduce long-term dependence on foreign assistance.
However, provisions relating to the sharing of health data and biological specimens have generated controversy across Africa. Ghana and Zimbabwe have reportedly rejected similar agreements over concerns about data protection, national sovereignty and the potential use of sensitive medical information by foreign organisations.
At least nine other African countries have reportedly accepted agreements containing data-sharing provisions.
Under the broader American framework, Washington has sought permission to share certain health information and biological specimens with up to 10 United States-based nongovernmental entities involved in developing diagnostic technologies and medical treatments. Such provisions have prompted questions about patient confidentiality, informed consent, ownership of biological materials and the commercial use of medical research. Zambian authorities maintain that their agreement limits data sharing to information required for programme monitoring and evaluation.
The deal represents a development in US-Zambia relations and could provide greater financial predictability for healthcare programmes. Nevertheless, the agreement’s long-term implications will depend on its implementation, the precise data-sharing safeguards and both governments’ ability to meet their financial commitments.
The separation of healthcare financing from mineral-resource negotiations remains a central feature of Zambia’s position, as the country seeks to protect its strategic economic interests while maintaining international health partnerships.



















